Evidence map›Paper›PMID 25551756›Full record

ArticlePloS one2014

The kidney transcriptome and proteome defined by transcriptomics and antibody-based profiling.

Masato Habuka, Linn Fagerberg, Björn M Hallström, Caroline Kampf, Karolina Edlund, Åsa Sivertsson, Tadashi Yamamoto, Fredrik Pontén, Mathias Uhlén, Jacob Odeberg

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Urate transport in health and disease.Best practice & research. Clinical rheumatology · 2021
    Review
  15. Article
  16. Review
  17. The Human Protein Atlas-Spatial localization of the human proteome in health and disease.Protein science : a publication of the Protein Society · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Masato HabukaSchool of Biotechnology, Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden; Department of Structural Pathology, Institute of Nephrology, Medical and Dental School, Niigata University, Asahimachi-dori Niigata, Japan.
Linn FagerbergSchool of Biotechnology, Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
Björn M HallströmSchool of Biotechnology, Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
Caroline KampfDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Karolina EdlundDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Åsa SivertssonSchool of Biotechnology, Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
Tadashi YamamotoDepartment of Structural Pathology, Institute of Nephrology, Medical and Dental School, Niigata University, Asahimachi-dori Niigata, Japan.
Fredrik PonténDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Mathias UhlénSchool of Biotechnology, Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
Jacob OdebergSchool of Biotechnology, Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden; Department of Medicine, Karolinska Institutet and Centre for Hematology, Karolinska University Hospital, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To understand renal functions and disease, it is important to define the molecular constituents of the various compartments of the kidney. Here, we used comparative transcriptomic analysis of all major organs and tissues in the human body, in combination with kidney tissue micro array based immunohistochemistry, to generate a comprehensive description of the kidney-specific transcriptome and proteome. A special emphasis was placed on the identification of genes and proteins that were elevated in specific kidney subcompartments. Our analysis identified close to 400 genes that had elevated expression in the kidney, as compared to the other analysed tissues, and these were further subdivided, depending on expression levels, into tissue enriched, group enriched or tissue enhanced. Immunohistochemistry allowed us to identify proteins with distinct localisation to the glomeruli (n = 11), proximal tubules (n = 120), distal tubules (n = 9) or collecting ducts (n = 8). Among the identified kidney elevated transcripts, we found several proteins not previously characterised or identified as elevated in kidney. This description of the kidney specific transcriptome and proteome provides a resource for basic and clinical research to facilitate studies to understand kidney biology and disease.

Indexed as

AgedBase SequenceFemaleGene Expression ProfilingHumansKidneyKidney GlomerulusKidney Tubules, CollectingKidney Tubules, DistalKidney Tubules, ProximalMaleMiddle AgedProteomeSequence Analysis, RNATranscriptomeProteome

Identifiers

PMID25551756
PMCPMC4281243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.